DE60321356D1 - Verfahren zur diagnostik von eierstock endometriose - Google Patents

Verfahren zur diagnostik von eierstock endometriose

Info

Publication number
DE60321356D1
DE60321356D1 DE60321356T DE60321356T DE60321356D1 DE 60321356 D1 DE60321356 D1 DE 60321356D1 DE 60321356 T DE60321356 T DE 60321356T DE 60321356 T DE60321356 T DE 60321356T DE 60321356 D1 DE60321356 D1 DE 60321356D1
Authority
DE
Germany
Prior art keywords
endometriosis
eggstock
diagnosis
methods
ovarian endometriosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60321356T
Other languages
German (de)
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of DE60321356D1 publication Critical patent/DE60321356D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60321356T 2002-08-30 2003-08-12 Verfahren zur diagnostik von eierstock endometriose Expired - Lifetime DE60321356D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40736502P 2002-08-30 2002-08-30
US45092003P 2003-02-28 2003-02-28
PCT/JP2003/010257 WO2004024952A1 (en) 2002-08-30 2003-08-12 Method of diagnosing ovarian endometriosis

Publications (1)

Publication Number Publication Date
DE60321356D1 true DE60321356D1 (de) 2008-07-10

Family

ID=31997699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60321356T Expired - Lifetime DE60321356D1 (de) 2002-08-30 2003-08-12 Verfahren zur diagnostik von eierstock endometriose

Country Status (7)

Country Link
EP (1) EP1537243B1 (cg-RX-API-DMAC7.html)
JP (2) JP4401295B2 (cg-RX-API-DMAC7.html)
AT (1) ATE397098T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003253440A1 (cg-RX-API-DMAC7.html)
CA (1) CA2497132A1 (cg-RX-API-DMAC7.html)
DE (1) DE60321356D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004024952A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005029089A2 (en) * 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis using tfpi-2 protein
MX2007009562A (es) * 2005-02-18 2008-03-11 Gov Health & Human Serv Identificacion de marcadores de diagnostico moleculares para endometriosis en linfocitos sanguineos.
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
EP2065707A1 (en) 2007-11-28 2009-06-03 Laboratorios S.A.L.V.A.T., S.A. Detection of endometrial secretion markers for assesment of endometriosis
CA2729403A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP5526378B2 (ja) * 2009-03-05 2014-06-18 国立大学法人山口大学 子宮頸癌の検出方法
CN102781964B (zh) 2009-12-28 2015-11-25 肿瘤疗法科学股份有限公司 抗cdh3抗体及其用途
JP5224308B2 (ja) * 2010-02-22 2013-07-03 公立大学法人横浜市立大学 卵巣明細胞腺癌に特異的に発現しているタンパク質とその応用
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2016011377A1 (en) * 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
JP6535357B2 (ja) * 2017-02-06 2019-06-26 国立研究開発法人農業・食品産業技術総合研究機構 非アルコール性脂肪肝治療用組成物、非アルコール性脂肪肝の治療剤の候補物質のスクリーニング方法及びｄｎａチップ
KR102897619B1 (ko) * 2018-04-20 2025-12-09 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 자궁내막증을 치료하기 위한 조성물 및 방법
CN110408695A (zh) * 2019-04-05 2019-11-05 辽宁省肿瘤医院 子宫内膜异位症恶变相关卵巢癌诊断或预后标志物及应用
JP7535270B2 (ja) * 2019-04-26 2024-08-16 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
WO2021215531A1 (ja) * 2020-04-24 2021-10-28 花王株式会社 月経周期マーカー
WO2024223379A1 (en) * 2023-04-27 2024-10-31 Scailyte Ag Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract
CN119769990B (zh) * 2024-12-26 2025-09-09 大连医科大学附属第二医院 子宫内膜异位症的检测系统和治疗剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828003A3 (en) * 1996-09-06 2003-01-15 SmithKline Beecham plc Human serine protease
GB9806104D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
DE69933661T3 (de) * 1998-04-15 2012-01-26 Merck Serono Biodevelopment Genomische sequenz des 5-lipoxygenase-aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU2001266787A1 (en) * 2000-06-07 2002-01-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6774223B2 (en) * 2000-06-28 2004-08-10 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
EP1202065A1 (en) * 2000-10-25 2002-05-02 Aventis Pharma S.A. Net, a transcription factor of the TCF family, as regulator of angiogenic expression.

Also Published As

Publication number Publication date
EP1537243B1 (en) 2008-05-28
ATE397098T1 (de) 2008-06-15
JP2005537027A (ja) 2005-12-08
CA2497132A1 (en) 2004-03-25
AU2003253440A8 (en) 2004-04-30
JP4401295B2 (ja) 2010-01-20
EP1537243A1 (en) 2005-06-08
WO2004024952A1 (en) 2004-03-25
JP4942052B2 (ja) 2012-05-30
JP2010029189A (ja) 2010-02-12
AU2003253440A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE510439T1 (de) Verfahren und vorrichtung zum bestimmen, übermitteln und/oder verwenden von verzögerungsinformationen
ATE496142T1 (de) Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
EP1788938A4 (en) SYSTEM, SOFTWARE AND METHOD FOR DETECTING SLEEP-BREATHTAKING USING AN ELECTRIC CARDIOGRAM
DE60223635D1 (de) Reagenzien, Verfahren und Vorrichtungen zum Nachweis von Analyten
EP1697024A4 (en) METHODS AND APPARATUS FOR IMPROVING ION-BASED SAMPLING DETECTION USING PRE-SEPARATION AND AMPLIFICATION
DE602004000494D1 (de) Vorrichtung und Verfahren zum Lesen der Seriennummern von Banknoten
DE602004010848D1 (de) Derivate von 1-piperazin- und 1-homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
ATA8612001A (de) Verfahren zum testen von software
DE60311200D1 (de) Vorrichtung und Verfahren zum Bereitstellen von Authentifizierungsinformationen für eine sichere Gruppenkommunikation
DE602004023824D1 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
DE602004021994D1 (de) Vorrichtung, Verfahren und Software zur Verfolgung von Gegenständen
ATE260678T1 (de) Verfahren zur detektion von endometriosis
DE60235211D1 (de) Verfahren zum Vorlöschen von Rauschen eines Bildes.
DE602004022105D1 (de) Vorrichtung, Verfahren und Software zur Verfolgung von Gegenständen
ATE468413T1 (de) Verfahren zur extraktion von platinmetallen
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE602005026249D1 (de) Vorrichtung, Verfahren und Computerprogrammprodukt zur Schätzung von Sicherheitsinformationen
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602005000975D1 (de) Verfahren zum Erkennen von Gegensteuern
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE60130970D1 (de) Reagenziensatz zur detektion von mikroorganismen, vorrichtung zur quantifizierungvon mikroorganismen und verfahren zur quantifizierung von mikroorganismen
ATE426039T1 (de) Verfahren fur den nachweis von streptococcus agalactiae mittels alpha-glucosidase-aktivitat
DE502004009594D1 (de) Verfahren zur Übertragung von Sensordaten

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN

8364 No opposition during term of opposition